Researchers explore DNA methylation patterns for early ovarian cancer detection, aiming to improve survival rates through ...

Researchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining the clinical limit of detection (LOD ...

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease. Liquid biopsies, which require just a ...

A new assay rapidly detects pancreatic ductal adenocarcinoma and differentiates it from noncancer pancreatic diseases by measuring cancer-associated protease activity in a small amount of blood.

In this evaluation of a cfDNA blood-based test, Shield, for the detection of colorectal cancer in an average-risk screening population, sensitivity for colorectal cancer was 83%, and specificity ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of the Vanguard Study — which will include up to 24,000 people ...

Researchers at Johns Hopkins University have discovered that specific blood tests can be used for the early detection of cancer. These tests can identify and diagnose cancer up to three years ...

Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD ...

A new blood test pioneered by diagnostics company AOA Dx (AOA) can detect ovarian cancer in symptomatic women with high ...